Membrane crystallization for the recovery of a pharmaceutical compound from waste streams
(2014) Chemical Engineering Research & Design — Vol. 92, p. 264-272 (2014)
Files
ChemicalEngineeringResearchandDesingxxx2013xxx-xxx.pdf
Restricted Access - Adobe PDF
- 2.1 MB
ChemicalEngineeringResearchandDesign922014264-272.pdf
Restricted Access - Adobe PDF
- 2.04 MB
Details
- Authors
- Abstract
- The recovery of the active pharmaceutical compound 1-(5-bromo-fur-2-il)-2-bromo-2-nitroethane (denoted as G-1) in a crystalline form from waste aqueous solutions using membrane crystallization is addressed in this work. The process conditions were evaluated, observing that a low flowrate of the feed solution (5.0 ml/min) is required to crystallize G-1. In addition, the use of Vitrofural as the feed solution, which is a mixture of G-1 and PEG, allows operating with higher concentrations due to the higher solubility of Vitrofural in water. However, the presence of PEG affects the mass transfer, leading to a lower transmembrane flux compared to the use of pure G-1. SEM images were used to evaluate the surface morphology of the crystallized G-1. It was concluded that the crystals obtained by membrane crystallization have the same morphology as the commercial G-1. Thus, the application of membrane crystallization for G-1 recovery can be considered as a novel technique with high potential to recover pharmaceutical compounds from waste streams. © 2013 The Institution of Chemical Engineers.
- Affiliations
Citations
Brito Martínez, M., Jullok, N., Rodríguez Negrín, Z., Van der Bruggen, B., & Luis Alconero, P. (2014). Membrane crystallization for the recovery of a pharmaceutical compound from waste streams. Chemical Engineering Research & Design, 92, 264-272. https://doi.org/10.1016/j.cherd.2013.07.029 (Original work published 2014)